Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Polymetal Acquires Goltsovoye Deposit

19 Nov 2008 07:21

RNS Number : 4527I
JSC Polymetal
19 November 2008
Β 

ο»Ώ

PolymetalΒ Agrees toΒ Acquire Goltsovoye Silver Deposit

Saint-Petersburg, Russia,Β NovemberΒ 19, 2008Β -Β JSCΒ "Polymetal"Β (LSE,Β MICEX,Β RTS: PMTL)Β ("Polymetal" or the "Company")Β announces that itΒ has made a proposalΒ to purchase 100% of CJSC "Artel of prospectors "Ayax" ("Ayax") from Ovoca GoldΒ Plc.Β forΒ US$11 million in cash,Β 7.5 million of Polymetal's common sharesΒ and a cash payment for such assets of Ayax as Polymetal agrees to acquireΒ based on their book valueΒ in addition to theΒ exploration and mining license forΒ Goltsovoye silver depositΒ located inΒ theΒ Magadan region of RussiaΒ ("Goltsovoye"), approximately 81 km from Polymetal's Dukat processing plant.

TheΒ transactionΒ is subject to agreeing detailed termsΒ with Ovoca Gold Plc. and approval fromΒ the shareholders of Ovoca Gold Plc. andΒ the Russian Federal Antimonopoly Service.

Measured and indicated silver resources at Goltsovoye, as estimated byΒ Wardell Armstrong InternationalΒ inΒ February 2007, amount toΒ 1.5Mt of ore atΒ anΒ average grade ofΒ 993g/t forΒ 47.2Moz of contained silver. Inferred resources, according to the same estimate, amount toΒ 0.9Mt atΒ 738g/t silver forΒ 21.8Moz contained silver. Average ore body width is approximately 2.5 metersΒ which the Company believes will allowΒ forΒ significant mechanization of the mine.

The conceptual mining plan prepared by Polymetal in the course of due diligenceΒ of GoltsovoyeΒ envisionsΒ aΒ 120-170Ktpa mechanized underground mineΒ with crushed oreΒ beingΒ trucked toΒ theΒ Dukat processing plant for blending with Dukat ore and flotation followed by cyanidation atΒ theΒ Lunnoye processing plant.

OreΒ metallurgy has been extensively tested indicating recoveries toΒ Dore in the order of 83-87%.Β Goltsovoe-type ore from one of Dukat's satellite deposits has been successfully processed at Dukat in 2007 confirming test results. The expanded gravity circuit at Dukat plant will provide for the presence of coarse-grained sulfides in the feed.

The Company believes that substantial exploration potential exists onΒ theΒ 5.6Β squareΒ kilometreΒ propertyΒ which is the subject of the Goltsovoye exploration and mining licenseΒ with onlyΒ twoΒ out of fiveΒ identifiedΒ ore zones drilled onΒ aΒ regular grid.

Polymetal's strategic rationale for the proposed transaction is as follows:

to expandΒ itsΒ silver resourceΒ baseΒ (Goltsovoye resources representΒ 10% of Polymetal's M&I andΒ 13% of MI&I resources as ofΒ January 1, 2008) in the vicinity of operating processing facilities with the ability to leverage existing infrastructure

to provide high-grade long-term feed toΒ theΒ expanded Dukat processing plantΒ 

to improveΒ theΒ cost position of Dukat/Lunnoye operationsΒ by adding higher-grade ore to the feed

to consolidate land position around Dukat andΒ ensureΒ maximum exposure to exploration upside in highly prospective silver belt

The goals the CompanyΒ hasΒ set forΒ Goltsovoye (assuming theΒ proposed acquisition of GoltsovoyeΒ closes in Q1 2009) areΒ to:

produceΒ aΒ JORC-compliant reserveΒ statementΒ with detailed development plan and capital/operating expenditures estimates in 3Q 2009

start capital development and infrastructure construction in 4Q 2009

start stoping in 2Q 2010

"Goltsovoye represents a unique opportunity to add high-grade silver resources literally in Dukat's backyard and thus leverage 90%-complete expansion of Dukat processing plant in the nearest future," said Vitaly Nesis, CEOΒ of Polymetal.Β "We are particularly pleased that this transactionΒ has a great potentialΒ toΒ becomeΒ strongly accretive on resource-per-share and, in the future, reserve-per-share and cash flow-per-share basis. It demonstrates Polymetal's continued focus on M&A opportunities that create substantial value for shareholders through easy-to-understand synergies".

Polymetal's Board of Directors is supportive of the potential transaction.

Pavel Danilin

VP, Corporate Finance and Investor Relations

Tel. +7Β 812Β 334 3666

E-mail:Β danilin@polymetal.ru

Website:Β www.polymetal.ru

Β 

***

This release includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the words "targets", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "would", "could" or "should" or similar expressions or, in each case their negative or other variations or by discussion of strategies, plans, objectives, goals, future events or intentions. These forward-looking statements all include matters that are not historical facts. By their nature, such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. Forward-looking statements are not guarantees of future performance. Many factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed in such forward-looking statements.Β These forward-looking statements speak only as at the date of this release. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

The release, publication or distribution of this announcement in jurisdictions other than theΒ United KingdomΒ or theΒ Russian FederationΒ may be restricted by law and, therefore, any persons who are subject to the law of any jurisdiction other than theΒ United KingdomΒ or theΒ Russian FederationΒ should inform themselves about, and observe, any applicable requirements. The information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outsideΒ EnglandΒ or theΒ Russian Federation.

This announcement does not constitute an offer or invitationΒ to purchase any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQBLBRTMMBBMPP
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.